Literature DB >> 11115765

Autocrine signals promote osteoblast survival in culture.

A Tumber1, M C Meikle, P A Hill.   

Abstract

We have studied the survival requirements of osteoblasts to test the hypothesis that osteoblasts undergo programmed cell death (PCD) or apoptosis unless they are continuously signalled by other cells not to do so. Osteoblasts survived for 6 days in culture at high cell density in the absence of other cell types, serum or exogenous proteins, but they died with the morphological features of apoptosis in these conditions at low cell density. Osteoblast survival was enhanced during the first 2 days of culture by the addition of the sulphydryl compound, cysteine to the culture medium which was converted intracellularly to the antioxidant glutathione. Catalase, an enzyme decomposing hydrogen peroxide, also protected the cells, whereas superoxide dismutase had no effect. Therefore, osteoblasts in culture are sensitive to toxic compounds derived from molecular oxygen, i.e. hydroxyl radicals or hydrogen peroxide spontaneously generated in CMRL medium containing ascorbate and ferrous ions. Conditioned medium from high density cultures prevented osteoblast apoptosis in low density cultures, as long as antioxidants were also present. The enhancing effect of conditioned medium on osteoblast survival was prevented by neutralizing antibodies to insulin-like growth factor-I (IGF-I) and IGF-II but not by antibodies to either platelet-derived growth factor (PDGF) or basic fibroblast growth factor (bFGF). These results suggest that in addition to regulating cell growth and differentiation, IGF-I and IGF-II also function as survival factors for osteoblasts. Our data also indicate that antioxidants are required for osteoblast survival and that they enhance growth factor mediated osteoblast survival.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115765     DOI: 10.1677/joe.0.1670383

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  7 in total

Review 1.  Autocrine and Paracrine Actions of IGF-I Signaling in Skeletal Development.

Authors:  Yongmei Wang; Daniel D Bikle; Wenhan Chang
Journal:  Bone Res       Date:  2013-09-25       Impact factor: 13.567

2.  Lactoferrin inhibits apoptosis through insulin-like growth factor I in primary rat osteoblasts.

Authors:  Jian-ming Hou; En-yu Chen; Shi-chao Wei; Fan Lin; Qing-ming Lin; Xu-hua Lan; Ying Xue; Man Wu
Journal:  Acta Pharmacol Sin       Date:  2014-02-24       Impact factor: 6.150

3.  A deletion causing spontaneous fracture identified from a candidate region of mouse Chromosome 14.

Authors:  Yan Jiao; Xinmin Li; Wesley G Beamer; Jian Yan; Yiai Tong; Daniel Goldowitz; Bruce Roe; Weikuan Gu
Journal:  Mamm Genome       Date:  2005-01       Impact factor: 2.957

4.  Insulin-like growth factor-1 isoforms in rat hepatocytes and cholangiocytes and their involvement in protection against cholestatic injury.

Authors:  Manuela Gatto; Veronica Drudi-Metalli; Alessia Torrice; Gianfranco Alpini; Alfredo Cantafora; Ida Blotta; Domenico Alvaro
Journal:  Lab Invest       Date:  2008-07-07       Impact factor: 5.662

5.  Impaired bone development and increased mesenchymal progenitor cells in calvaria of RB1-/- mice.

Authors:  Gabriel M Gutierrez; Elizabeth Kong; Yves Sabbagh; Nelson E Brown; Jong-Seo Lee; Marie B Demay; David M Thomas; Philip W Hinds
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-19       Impact factor: 11.205

6.  Effect of vitronectin bound to insulin-like growth factor-I and insulin-like growth factor binding protein-3 on porcine enamel organ-derived epithelial cells.

Authors:  Yoshinori Shinohara; Shuhei Tsuchiya; Kazuo Hatae; Masaki J Honda
Journal:  Int J Dent       Date:  2012-04-10

Review 7.  Association of the insulin-like growth factor-1 single nucleotide polymorphisms rs35767, rs2288377, and rs5742612 with osteoporosis risk: A meta-analysis.

Authors:  Ying-Chun Chen; Lin Zhang; Er-Nan Li; Li-Xiang Ding; Gen-Ai Zhang; Yu Hou; Wei Yuan
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.